Whether you are addressing a known cardiovascular liability or aiming to de-risk compounds early, Clyde Biosciences provides rapid, high-quality data to support your development decisions.

•Most standard studies completed within 2 weeks

•Designed for discovery through IND-enabling studies

•Tailored study design with expert scientific support

Improve prediction of human cardiac risk, define drug efficacy, reduce late-stage failure, and generate data aligned with regulatory expectations

To enquire about how Clyde could help with your project complete the enquiry form below and we’ll be get back to you as soon as we can. Alternatively email us at info@clydebio.com